i- On November 17, the FDA updated its Leafy Green STEC Action Plan (LGAP). FDA first released the LGAP in 2020 following recurring outbreaks linked to leafy greens caused by Shiga toxin-producing E. Coli (STEC).
- The update provides additional information on sampling assignments, method developments, and a status update on FDA’s long term longitudinal studies in Arizona and California. The Agency also released a new fact sheet: Adjacent and Nearby Land Uses and their impact on the safety of produce grown nearby.
- The LGAP is part of the FDA’s yearslong efforts, in collaboration with partners in the public and private sectors, to enhance the safety of leafy greens. Per FDA, this work has included “prioritized inspections, focused sampling, stakeholder engagement and collaboration, data sharing, root cause investigations, and advancements in the science of detection and prevention.”
- FDA also noted that the Agency intends to discuss their vision for produce safety efforts after the transition to the Human Foods Program in early 2024.
FDA Published Updated Leafy Green STEC Action Plan
Wednesday, November 22, 2023
Current Legal Analysis
More from Keller and Heckman LLP
Upcoming Legal Education Events
May
22
2024
May
17
2024
